Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.
Código da empresaAXGN
Nome da EmpresaAxoGen Inc
Data de listagemDec 17, 1986
CEOMr. Michael Donald (Mike) Dale
Número de funcionários451
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 17
Endereço13631 Progress Blvd.
CidadeALACHUA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal32615
Telefone13864626817
Sitehttps://www.axogeninc.com/
Código da empresaAXGN
Data de listagemDec 17, 1986
CEOMr. Michael Donald (Mike) Dale
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados